Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

Details

Language :

English

ISSN :

15228517

Volume :

26

Issue :

4

Database :

Complementary Index

Journal :

Neuro-Oncology

Publication Type :

Academic Journal

Accession number :

176468349

Full Text :

https://doi.org/10.1093/neuonc/noad224